These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 31075412)
1. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway. Li B; Liu D; Yang P; Li HY; Wang D Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412 [TBL] [Abstract][Full Text] [Related]
2. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway. Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391 [TBL] [Abstract][Full Text] [Related]
3. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression. Liu C; Li J; Wang W; Zhong X; Xu F; Lu J Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127 [TBL] [Abstract][Full Text] [Related]
4. miR-365 regulates liver cancer stem cells via RAC1 pathway. Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377 [TBL] [Abstract][Full Text] [Related]
5. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway. Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway. Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743 [TBL] [Abstract][Full Text] [Related]
7. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients. Xiang D; Cheng Z; Liu H; Wang X; Han T; Sun W; Li X; Yang W; Chen C; Xia M; Liu N; Yin S; Jin G; Lee T; Dong L; Hu H; Wang H; Ding J Hepatology; 2017 May; 65(5):1566-1580. PubMed ID: 28059452 [TBL] [Abstract][Full Text] [Related]
8. miR-124 regulates liver cancer stem cells expansion and sorafenib resistance. Feng Y; Jiang W; Zhao W; Lu Z; Gu Y; Dong Y Exp Cell Res; 2020 Sep; 394(2):112162. PubMed ID: 32640195 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype. Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543 [TBL] [Abstract][Full Text] [Related]
10. Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma. Liu C; Liu L; Chen X; Cheng J; Zhang H; Shen J; Shan J; Xu Y; Yang Z; Lai M; Qian C Hepatology; 2016 Jul; 64(1):117-29. PubMed ID: 26910875 [TBL] [Abstract][Full Text] [Related]
11. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma. Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246 [TBL] [Abstract][Full Text] [Related]
12. LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma. Yan S; Shan X; Chen K; Liu Y; Yu G; Chen Q; Zeng T; Zhu L; Dang H; Chen F; Ling J; Huang A; Tang H Gene; 2018 Dec; 679():138-149. PubMed ID: 30098428 [TBL] [Abstract][Full Text] [Related]
13. miR-4461 inhibits liver cancer stem cells expansion and chemoresistance via regulating SIRT1. Yang D; Zhang P; Yang Z; Hou G; Yang Z Carcinogenesis; 2024 Jul; 45(7):463-474. PubMed ID: 36437743 [TBL] [Abstract][Full Text] [Related]
14. miR-219 regulates liver cancer stem cell expansion via E-cadherin pathway. Si A; Wang L; Miao K; Zhang R; Ji H; Lei Z; Cheng Z; Fang X; Hao B Cell Cycle; 2019 Dec; 18(24):3550-3561. PubMed ID: 31724462 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214 [TBL] [Abstract][Full Text] [Related]
16. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway. Song S; Sun K; Dong J; Zhao Y; Liu F; Liu H; Sha Z; Mao J; Ding G; Guo W; Fu Z Exp Cell Res; 2020 Feb; 387(2):111781. PubMed ID: 31857112 [TBL] [Abstract][Full Text] [Related]
17. miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients. Li J; Zhong X; Wang X; Xu F; Yang J; Lu J; Liu C; Lu J Arch Biochem Biophys; 2021 May; 703():108871. PubMed ID: 33831356 [TBL] [Abstract][Full Text] [Related]
18. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma. Ma XL; Hu B; Tang WG; Xie SH; Ren N; Guo L; Lu RQ J Hematol Oncol; 2020 Feb; 13(1):11. PubMed ID: 32024555 [TBL] [Abstract][Full Text] [Related]
19. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269 [TBL] [Abstract][Full Text] [Related]
20. The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma. Tsai SC; Lin CC; Shih TC; Tseng RJ; Yu MC; Lin YJ; Hsieh SY Mol Carcinog; 2017 Sep; 56(9):2035-2047. PubMed ID: 28383782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]